Cargando…
Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study
As P-glycoprotein (Pgp) inhibition at the blood–brain barrier (BBB) after administration of a single dose of tariquidar is transient, we performed positron emission tomography (PET) scans with the Pgp substrate (R)-[(11)C]verapamil in five healthy volunteers during continuous intravenous tariquidar...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420865/ https://www.ncbi.nlm.nih.gov/pubmed/25669913 http://dx.doi.org/10.1038/jcbfm.2015.19 |
_version_ | 1782369768142012416 |
---|---|
author | Bauer, Martin Karch, Rudolf Zeitlinger, Markus Philippe, Cécile Römermann, Kerstin Stanek, Johann Maier-Salamon, Alexandra Wadsak, Wolfgang Jäger, Walter Hacker, Marcus Müller, Markus Langer, Oliver |
author_facet | Bauer, Martin Karch, Rudolf Zeitlinger, Markus Philippe, Cécile Römermann, Kerstin Stanek, Johann Maier-Salamon, Alexandra Wadsak, Wolfgang Jäger, Walter Hacker, Marcus Müller, Markus Langer, Oliver |
author_sort | Bauer, Martin |
collection | PubMed |
description | As P-glycoprotein (Pgp) inhibition at the blood–brain barrier (BBB) after administration of a single dose of tariquidar is transient, we performed positron emission tomography (PET) scans with the Pgp substrate (R)-[(11)C]verapamil in five healthy volunteers during continuous intravenous tariquidar infusion. Total distribution volume (V(T)) of (R)-[(11)C]verapamil in whole-brain gray matter increased by 273±78% relative to baseline scans without tariquidar, which was higher than previously reported V(T) increases. During tariquidar infusion whole-brain V(T) was comparable to V(T) in the pituitary gland, a region not protected by the BBB, which suggested that we were approaching complete Pgp inhibition at the human BBB. |
format | Online Article Text |
id | pubmed-4420865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-44208652015-05-15 Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study Bauer, Martin Karch, Rudolf Zeitlinger, Markus Philippe, Cécile Römermann, Kerstin Stanek, Johann Maier-Salamon, Alexandra Wadsak, Wolfgang Jäger, Walter Hacker, Marcus Müller, Markus Langer, Oliver J Cereb Blood Flow Metab Brief Communication As P-glycoprotein (Pgp) inhibition at the blood–brain barrier (BBB) after administration of a single dose of tariquidar is transient, we performed positron emission tomography (PET) scans with the Pgp substrate (R)-[(11)C]verapamil in five healthy volunteers during continuous intravenous tariquidar infusion. Total distribution volume (V(T)) of (R)-[(11)C]verapamil in whole-brain gray matter increased by 273±78% relative to baseline scans without tariquidar, which was higher than previously reported V(T) increases. During tariquidar infusion whole-brain V(T) was comparable to V(T) in the pituitary gland, a region not protected by the BBB, which suggested that we were approaching complete Pgp inhibition at the human BBB. Nature Publishing Group 2015-05 2015-02-11 /pmc/articles/PMC4420865/ /pubmed/25669913 http://dx.doi.org/10.1038/jcbfm.2015.19 Text en Copyright © 2015 International Society for Cerebral Blood Flow & Metabolism, Inc. http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Brief Communication Bauer, Martin Karch, Rudolf Zeitlinger, Markus Philippe, Cécile Römermann, Kerstin Stanek, Johann Maier-Salamon, Alexandra Wadsak, Wolfgang Jäger, Walter Hacker, Marcus Müller, Markus Langer, Oliver Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study |
title | Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study |
title_full | Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study |
title_fullStr | Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study |
title_full_unstemmed | Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study |
title_short | Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study |
title_sort | approaching complete inhibition of p-glycoprotein at the human blood–brain barrier: an (r)-[(11)c]verapamil pet study |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420865/ https://www.ncbi.nlm.nih.gov/pubmed/25669913 http://dx.doi.org/10.1038/jcbfm.2015.19 |
work_keys_str_mv | AT bauermartin approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT karchrudolf approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT zeitlingermarkus approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT philippececile approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT romermannkerstin approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT stanekjohann approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT maiersalamonalexandra approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT wadsakwolfgang approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT jagerwalter approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT hackermarcus approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT mullermarkus approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy AT langeroliver approachingcompleteinhibitionofpglycoproteinatthehumanbloodbrainbarrieranr11cverapamilpetstudy |